High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature

Leukemia and Lymphoma

Volumn 54, Issue 8, 2013, Pages 1652-1657

  Herold, Tobias ^a,b   Mulaw, Medhanie A ^a,b   Jurinovic, Vindi ^a   Seiler, Till ^a,b   Metzeler, Klaus H ^a   Dufour, Annika ^a   Schneider, Stephanie ^a   Kakadia, Purvi M ^a,b   Spiekermann, Karsten ^a,b   Mansmann, Ulrich ^a   Hiddemann, Wolfgang ^a,b   Buske, Christian ^c   Dreyling, Martin ^a,b   Bohlander, Stefan K ^a,b,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Gene expression; Lymphoma; MZB1; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; MARGINAL ZONE B AND B1 CELL SPECIFIC PROTEIN; PREDNISONE; RITUXIMAB; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME;

CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MULTIPLE MYELOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; TRANSCRIPTOME;

EID: 84880309433     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.753445     Document Type: Article

References (31)

1. de Bono J S, Ashwortha. Translating cancer research into targeted therapeutics. Nature 2010; 467: 543-549
2. Gribben JG. How I treat CLL up front. Blood 2010 ; 115 : 187-197
3. Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005 ; 106 : 650-657
4. Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105-111
5. Fridberg M, Servin A, Anagnostaki L, et a l. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma 2007; 48: 2221-2232
6. Dave S S, Wright G, Tan B, et a l. Prediction of survival in follicular lymphoma based on molecular features of tumor-infi ltrating immune cells. NEngl J Med 2004; 351: 2159-2169
7. Nogai H, Dorken B, Lenz G. Pathogenesis of non-Hodgkin slymphoma. J Clin Oncol 2011 ; 29 : 1803-1811
8. Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. NEngl J Med 2008; 359: 2313-2323
9. Herold T, Jurinovic V, Metzeler KH, et al. An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia. Leukemia 2011; 25: 1639-1645
10. Katoh M, Katoh M. MGC29506 gene, frequently down-regulated in intestinal-Type gastric cancer, encodes secreted-Type protein with conserved cysteine residues. Int J Oncol 2003 ; 23 : 235-241
11. van Anken E, Pena F, Hafkemeijer N, et al. Efficient IgM assembly and secretion require the plasma cell induced endo -plasmic reticulum protein pERp1. Proc Natl Acad Sci USA 2009 ; 106 : 17019-17024
12. Shimizu Y, Meunier L, Hendershot L M. pERp1 is signifi cantly up-regulated during plasma cell differentiation and contributes to the oxidative folding of immunoglobulin. Proc Natl Acad Sci USA 2009 ; 106 : 17013-17018
13. Flach H, Rosenbaum M, Duchniewicz M, et a l. Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells. Immunity 2010; 33: 723-735
14. Herold T, Jurinovic V, Mulaw M, et al. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20. Genes Chromosomes Cancer 2011 ; 50 : 546-558
15. Leich E, Salaverria I, Bea S, et al. Follicular lymphomas withand without translocation t(14;18) differ in gene expression profi les and genetic alterations. Blood 2009 ; 114 : 826-834
16. Zhan F, Barlogie B, Arzoumanian V, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007 ; 109 : 1692-1700
17. Metzeler KH, Hummel M, Bloomfi eld CD, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 2008 ; 112 : 4193-4201
18. RDevelopment Core Team. R: A language and environment for statistical computing. 2011. RFoundation for Statistical Computing, Vienna, Austria. Available from: http://www.r-project.org/
19. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5 : R80
20. Pham LV, Tamayo AT, Li C, et al. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growthand survival genes in diffuse large B-cell lymphomas. Blood 2010 ; 116 : 3899-3906
21. Northrop JP, Ho SN, Chen L, et al. NF-AT components defi ne a family of transcription factors targeted in T-cell activation. Nature 1994 ; 369 : 497-502
22. Marafi oti T, Pozzobon M, Hansmann M L, et a l. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol 2005 ; 128 : 333-342
23. Dow LE, Elsum IA, King CL, et al. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008; 27: 5988-6001
24. Hansen JB, Petersen RK, Jorgensen C, et al. Deregulated MAPK activity prevents adipocyte differentiation of fi broblasts lacking the retinoblastoma protein. JBiol Chem 2002 ; 277 : 26335-26339
25. Wilkinson B, Gilbert HF. Protein disulfi de isomerase. Biochim Biophys Acta 2004 ; 1699 : 35-44
26. Gruber CW, Cemazar M, Heras B, et al. Protein disulfi de isomerase: The structure of oxidative folding. Trends Biochem Sci 2006 ; 31 : 455-464
27. Hatahet F, Ruddock L W. Substrate recognition by the protein disulfi de isomerases. FEBS J 2007 ; 274 : 5223-5234
28. Hatahet F, Ruddock L W. Protein disulfi de isomerase: A critical evaluation of its function in disulfi de bond formation. Antioxid Redox Signal 2009; 11: 2807-2850
29. Moenner M, Pluquet O, Bouchecareilh M, et al. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007 ; 67 : 10631-10634
30. Perez-Galan P, Mora-Jensen H, Weniger MA, et al. Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood 2011 ; 117 : 542-552
31. Dunleavy K, Pittaluga S, Czuczman MS, et al. Differential Efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 2009; 113: 6069-6076